Provenance du réseau au premier degré de Martin Busch
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
AaviGen GmbH
 AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Martin Busch via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
uniQure GmbH
 uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Biotechnology | Founder Founder |
Statistiques
Internationale
| Allemagne | 2 |
Sectorielle
| Health Technology | 2 |
Opérationnelle
| Founder | 5 |
| Chief Executive Officer | 1 |
| Sales & Marketing | 1 |
| Director of Finance/CFO | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Patrick Most | 2 |
| Hugo Katus | 2 |
| Marc Lerchenmueller | 1 |
- Bourse
- Insiders
- Martin Busch
- Connexions Sociétés
